Latest DrugPrices News and Updates : DrugPrices updates, DrugPrices News , DrugPrices around the world

Nishadil

Washington | 20°C (overcast clouds)

Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws

Top story

Rare‑Disease Biotechs Push Back on Trump’s Price‑Cut Push While PBMs Slip Around State Laws

In focus

Latest feed

Rare Disease Makers Push Back on Medicare Price‑Cut Pilots

Rare‑Disease Makers Push for Medicare Price‑Cut Exemptions

India Takes a Big Step: Capping Prices on Key New Medicines

A Champion for Hope: How Trump Aims to Revolutionize Cancer Care

Latest headlines

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

A New Dawn: Roche's Landmark Drug Redefines Hope for KRAS-Driven Lung Cancer Patients

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Budgetary Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

The GLP-1 Revolution: A Financial Tightrope for Medicare and Medicaid

The High-Stakes Battle: Why Pharmacy Benefit Managers Are Fighting Tooth and Nail

The High-Stakes Battle: Why Pharmacy Benefit Managers Are Fighting Tooth and Nail

The Dawn of Autonomous Drug Discovery: Prometheus Secures Staggering $1.2 Billion for AI-Powered Engineers

The Dawn of Autonomous Drug Discovery: Prometheus Secures Staggering $1.2 Billion for AI-Powered Engineers

Prometheus Biosciences Secures Whopping $1.2 Billion: Unleashing the Era of 'Artificial Engineers'

Prometheus Biosciences Secures Whopping $1.2 Billion: Unleashing the Era of 'Artificial Engineers'

A Crisis Averted? India's Tough Choice on Cancer Drug Prices Amid Shortages

A Crisis Averted? India's Tough Choice on Cancer Drug Prices Amid Shortages

India's Bold Move: Allowing Cancer Drug Price Hikes to Tackle Shortages

India's Bold Move: Allowing Cancer Drug Price Hikes to Tackle Shortages

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 GLP‑1 Weight‑Loss Plan: What the Numbers Really Mean

Medicare’s $50 Weight‑Loss Drug Plan: What the Numbers Really Mean

Medicare’s $50 Weight‑Loss Drug Plan: What the Numbers Really Mean

The Unveiling of Trump's Most Favored Nation Drug Pricing Secrets

The Unveiling of Trump's Most Favored Nation Drug Pricing Secrets

The Unveiling: Trump's Most Favored Nation Drug Pricing Secrets Are About To Surface

The Unveiling: Trump's Most Favored Nation Drug Pricing Secrets Are About To Surface

A New Dawn in Medicine: Kailera's Triple-G Drug Unveils Staggering Potential

A New Dawn in Medicine: Kailera's Triple-G Drug Unveils Staggering Potential

Immunovant's Batoclimab Shakes Up Arthritis Treatment Hopes with Promising Trial Data

Immunovant's Batoclimab Shakes Up Arthritis Treatment Hopes with Promising Trial Data

TrumpRx’s Generic Drug Push Falters as Cassidy’s FDA Battle Deepens

TrumpRx’s Generic Drug Push Falters as Cassidy’s FDA Battle Deepens

The Great Generic Drug Revolution: Mark Cuban, 'TrumpRx,' and the Fight for Affordable Medicine

The Great Generic Drug Revolution: Mark Cuban, 'TrumpRx,' and the Fight for Affordable Medicine

Supreme Court’s Decision Keeps Medicare Drug Price Cuts in Place

Supreme Court’s Decision Keeps Medicare Drug Price Cuts in Place

Supreme Court Weighs In on Medicare Drug‑Price Negotiations

Supreme Court Weighs In on Medicare Drug‑Price Negotiations

The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s

The Future of US Pharma: Dr. Reddy's CEO Predicts Biosimilars to Eclipse Generics by Early 2030s

Senator Warren Slams Trump's 'Mathematically Impossible' Drug Price Claim

Senator Warren Slams Trump's 'Mathematically Impossible' Drug Price Claim

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

The Audacious Pivot: How Kelonia Rose from the Brink to a $3 Billion Gene Therapy Vision

The Unlocking of a Legend: How Science Finally Conquered KRAS, the 'Undruggable' Cancer Foe

The Unlocking of a Legend: How Science Finally Conquered KRAS, the 'Undruggable' Cancer Foe

America's Medicine Cabinet: Unpacking the Tariffs Debate and Our Global Drug Reliance

America's Medicine Cabinet: Unpacking the Tariffs Debate and Our Global Drug Reliance

The Cost Conundrum: Unpacking Massachusetts' Sky-High Healthcare Bills

The Cost Conundrum: Unpacking Massachusetts' Sky-High Healthcare Bills

Essential Medicines: DRAP Dispels Price Hike Rumors Amid Global Uncertainty

Essential Medicines: DRAP Dispels Price Hike Rumors Amid Global Uncertainty

The Unforeseen Ripple: How Trump's Drug Pricing Push Could Have Raised Global Costs

The Unforeseen Ripple: How Trump's Drug Pricing Push Could Have Raised Global Costs

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

A Game Changer for Health: Generic Semaglutide Slashes Prices in India, Offering New Hope

Global Turmoil Squeezes India's Pharma: Drugmakers Plead for Input Price Caps

Global Turmoil Squeezes India's Pharma: Drugmakers Plead for Input Price Caps

The Uncharted Alliance: Klotho Neurosciences Forges Unexpected Path with Greenland Mining Giant

The Uncharted Alliance: Klotho Neurosciences Forges Unexpected Path with Greenland Mining Giant

The Persistent Ache: Why Affordable Drug Prices Remain an Elusive Dream for Americans

The Persistent Ache: Why Affordable Drug Prices Remain an Elusive Dream for Americans

An Unexpected Turn: America's Drug Price Paradox

An Unexpected Turn: America's Drug Price Paradox

A Real Plan to Tackle Soaring Drug Costs

A Real Plan to Tackle Soaring Drug Costs

Trump Launches TrumpRx: A Digital Crusade Against Sky-High Drug Prices

Trump Launches TrumpRx: A Digital Crusade Against Sky-High Drug Prices

AstraZeneca's Bold Bet: Charging Hard into China's Obesity Drug Race and Beyond

AstraZeneca's Bold Bet: Charging Hard into China's Obesity Drug Race and Beyond

The Cost of Cures: Unpacking America's Enduring Drug Price Predicament

The Cost of Cures: Unpacking America's Enduring Drug Price Predicament

Unpacking the Ambition: Trump's Most-Favored-Nation Drug Pricing Push

Unpacking the Ambition: Trump's Most-Favored-Nation Drug Pricing Push

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

The 'Skinny Label' Showdown: How a Supreme Court Case Could Redefine Generics and Drug Prices

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech

Load more